Page last updated: 2024-09-03

pre 084 and oxidopamine

pre 084 has been researched along with oxidopamine in 3 studies

Compound Research Comparison

Studies
(pre 084)
Trials
(pre 084)
Recent Studies (post-2010)
(pre 084)
Studies
(oxidopamine)
Trials
(oxidopamine)
Recent Studies (post-2010) (oxidopamine)
1160738,63062,407

Protein Interaction Comparison

ProteinTaxonomypre 084 (IC50)oxidopamine (IC50)
Glyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)8
DNA repair protein RAD52 homologHomo sapiens (human)0.779

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Bez, F; Cenci, MA; Francardo, V; Nissbrandt, H; Ruscher, K; Wieloch, T1
Kadnikov, IA; Seredenin, SB; Voronin, MV; Voronkov, DN1
Cao, T; Guo, CH; Waddington, JL; Zhen, XC; Zheng, LT1

Other Studies

3 other study(ies) available for pre 084 and oxidopamine

ArticleYear
Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism.
    Brain : a journal of neurology, 2014, Volume: 137, Issue:Pt 7

    Topics: Adrenergic Agents; Animals; Antiparkinson Agents; Brain; Disease Models, Animal; Dopamine; Exploratory Behavior; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mice, Knockout; Morpholines; Oxidopamine; Parkinsonian Disorders; Psychomotor Performance; Receptors, sigma; Serotonin; Sigma-1 Receptor

2014
Chaperone Sigma1R mediates the neuroprotective action of afobazole in the 6-OHDA model of Parkinson's disease.
    Scientific reports, 2019, 11-19, Volume: 9, Issue:1

    Topics: Animals; Benzimidazoles; Corpus Striatum; Disease Models, Animal; Dopamine; Ethylenediamines; Male; Mice; Mice, Inbred ICR; Morpholines; Neurons; Neuroprotection; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Receptors, sigma; Rotarod Performance Test; Sigma-1 Receptor; Substantia Nigra

2019
Development and characterization of an inducible Dicer conditional knockout mouse model of Parkinson's disease: validation of the antiparkinsonian effects of a sigma-1 receptor agonist and dihydromyricetin.
    Acta pharmacologica Sinica, 2020, Volume: 41, Issue:4

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; DEAD-box RNA Helicases; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Flavonols; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Morpholines; Oxidopamine; Parkinson Disease; Receptors, sigma; Ribonuclease III; Sigma-1 Receptor; Tamoxifen

2020